Electromed Inc. (ELMD)
SmartVest - Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
SmartVest - Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
National CineMedia, Inc. to Acquire Captivate for $275 Million, Creating the Leading Premium Video and Digital Out-of-Home Advertising Platform
Comscore Announces ROI Strategy to Transform the Business
Grove Receives NYSE Continued Listing Standards Notice
ESS Tech, Inc. Announces Second Quarter 2026 Financial Results
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
Jack Henry Announces Fiscal 2026 Fourth Quarter and Full-Year Deconversion Revenue Results
GrowGeneration Reports Second Quarter 2026 Financial Results
Spectral AI Announces 2026 Second Quarter Financial Results
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update